Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 10 |
NetGPI | no | yes: 0, no: 10 |
Related structures:
AlphaFold database: A4HRQ6
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 103 | 107 | PF00656 | 0.530 |
CLV_NRD_NRD_1 | 136 | 138 | PF00675 | 0.483 |
CLV_NRD_NRD_1 | 150 | 152 | PF00675 | 0.366 |
CLV_NRD_NRD_1 | 187 | 189 | PF00675 | 0.666 |
CLV_NRD_NRD_1 | 308 | 310 | PF00675 | 0.577 |
CLV_NRD_NRD_1 | 33 | 35 | PF00675 | 0.412 |
CLV_NRD_NRD_1 | 41 | 43 | PF00675 | 0.408 |
CLV_PCSK_KEX2_1 | 11 | 13 | PF00082 | 0.504 |
CLV_PCSK_KEX2_1 | 136 | 138 | PF00082 | 0.522 |
CLV_PCSK_KEX2_1 | 150 | 152 | PF00082 | 0.407 |
CLV_PCSK_KEX2_1 | 187 | 189 | PF00082 | 0.644 |
CLV_PCSK_KEX2_1 | 310 | 312 | PF00082 | 0.559 |
CLV_PCSK_KEX2_1 | 33 | 35 | PF00082 | 0.360 |
CLV_PCSK_PC1ET2_1 | 11 | 13 | PF00082 | 0.504 |
CLV_PCSK_PC1ET2_1 | 310 | 312 | PF00082 | 0.554 |
CLV_PCSK_PC1ET2_1 | 33 | 35 | PF00082 | 0.497 |
CLV_PCSK_SKI1_1 | 102 | 106 | PF00082 | 0.565 |
CLV_PCSK_SKI1_1 | 202 | 206 | PF00082 | 0.647 |
CLV_PCSK_SKI1_1 | 311 | 315 | PF00082 | 0.595 |
CLV_PCSK_SKI1_1 | 34 | 38 | PF00082 | 0.411 |
DEG_APCC_DBOX_1 | 135 | 143 | PF00400 | 0.438 |
DOC_ANK_TNKS_1 | 277 | 284 | PF00023 | 0.615 |
DOC_CKS1_1 | 195 | 200 | PF01111 | 0.689 |
DOC_CKS1_1 | 232 | 237 | PF01111 | 0.680 |
DOC_CYCLIN_RxL_1 | 31 | 40 | PF00134 | 0.414 |
DOC_MAPK_gen_1 | 172 | 182 | PF00069 | 0.476 |
DOC_USP7_MATH_1 | 203 | 207 | PF00917 | 0.622 |
DOC_USP7_MATH_1 | 211 | 215 | PF00917 | 0.494 |
DOC_USP7_MATH_1 | 222 | 226 | PF00917 | 0.498 |
DOC_USP7_MATH_1 | 227 | 231 | PF00917 | 0.545 |
DOC_USP7_MATH_1 | 263 | 267 | PF00917 | 0.631 |
DOC_USP7_MATH_1 | 271 | 275 | PF00917 | 0.626 |
DOC_USP7_UBL2_3 | 229 | 233 | PF12436 | 0.586 |
DOC_USP7_UBL2_3 | 31 | 35 | PF12436 | 0.514 |
DOC_WW_Pin1_4 | 194 | 199 | PF00397 | 0.624 |
DOC_WW_Pin1_4 | 231 | 236 | PF00397 | 0.678 |
LIG_14-3-3_CanoR_1 | 12 | 20 | PF00244 | 0.484 |
LIG_14-3-3_CanoR_1 | 188 | 198 | PF00244 | 0.766 |
LIG_14-3-3_CanoR_1 | 250 | 259 | PF00244 | 0.648 |
LIG_14-3-3_CanoR_1 | 261 | 268 | PF00244 | 0.504 |
LIG_14-3-3_CanoR_1 | 296 | 301 | PF00244 | 0.545 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.409 |
LIG_FHA_2 | 125 | 131 | PF00498 | 0.566 |
LIG_FHA_2 | 203 | 209 | PF00498 | 0.633 |
LIG_FHA_2 | 55 | 61 | PF00498 | 0.562 |
LIG_FHA_2 | 74 | 80 | PF00498 | 0.308 |
LIG_LIR_Apic_2 | 299 | 303 | PF02991 | 0.645 |
LIG_LIR_Gen_1 | 92 | 101 | PF02991 | 0.402 |
LIG_LIR_Nem_3 | 92 | 97 | PF02991 | 0.514 |
LIG_MAD2 | 188 | 196 | PF02301 | 0.607 |
LIG_PTB_Apo_2 | 93 | 100 | PF02174 | 0.461 |
LIG_SH2_CRK | 300 | 304 | PF00017 | 0.654 |
LIG_SH2_GRB2like | 94 | 97 | PF00017 | 0.461 |
LIG_SH2_SRC | 44 | 47 | PF00017 | 0.515 |
LIG_SH2_STAP1 | 44 | 48 | PF00017 | 0.401 |
LIG_SH3_3 | 195 | 201 | PF00018 | 0.680 |
LIG_TRAF2_1 | 129 | 132 | PF00917 | 0.413 |
LIG_TRAF2_1 | 16 | 19 | PF00917 | 0.529 |
LIG_TRAF2_1 | 206 | 209 | PF00917 | 0.676 |
MOD_CDK_SPK_2 | 197 | 202 | PF00069 | 0.735 |
MOD_CK1_1 | 237 | 243 | PF00069 | 0.691 |
MOD_CK1_1 | 266 | 272 | PF00069 | 0.612 |
MOD_CK2_1 | 11 | 17 | PF00069 | 0.521 |
MOD_CK2_1 | 124 | 130 | PF00069 | 0.566 |
MOD_CK2_1 | 162 | 168 | PF00069 | 0.571 |
MOD_CK2_1 | 202 | 208 | PF00069 | 0.634 |
MOD_CK2_1 | 54 | 60 | PF00069 | 0.542 |
MOD_CK2_1 | 73 | 79 | PF00069 | 0.299 |
MOD_GlcNHglycan | 205 | 208 | PF01048 | 0.626 |
MOD_GlcNHglycan | 213 | 216 | PF01048 | 0.553 |
MOD_GlcNHglycan | 224 | 227 | PF01048 | 0.617 |
MOD_GlcNHglycan | 236 | 239 | PF01048 | 0.693 |
MOD_GlcNHglycan | 255 | 258 | PF01048 | 0.617 |
MOD_GlcNHglycan | 273 | 276 | PF01048 | 0.682 |
MOD_GSK3_1 | 190 | 197 | PF00069 | 0.587 |
MOD_GSK3_1 | 227 | 234 | PF00069 | 0.673 |
MOD_GSK3_1 | 239 | 246 | PF00069 | 0.607 |
MOD_GSK3_1 | 249 | 256 | PF00069 | 0.648 |
MOD_GSK3_1 | 257 | 264 | PF00069 | 0.555 |
MOD_PIKK_1 | 261 | 267 | PF00454 | 0.570 |
MOD_PKA_1 | 11 | 17 | PF00069 | 0.521 |
MOD_PKA_2 | 11 | 17 | PF00069 | 0.521 |
MOD_PKA_2 | 122 | 128 | PF00069 | 0.485 |
MOD_PKA_2 | 249 | 255 | PF00069 | 0.745 |
MOD_Plk_1 | 73 | 79 | PF00069 | 0.514 |
MOD_Plk_2-3 | 124 | 130 | PF00069 | 0.511 |
MOD_Plk_4 | 263 | 269 | PF00069 | 0.565 |
MOD_ProDKin_1 | 194 | 200 | PF00069 | 0.626 |
MOD_ProDKin_1 | 231 | 237 | PF00069 | 0.680 |
TRG_DiLeu_BaEn_1 | 51 | 56 | PF01217 | 0.464 |
TRG_DiLeu_BaEn_2 | 207 | 213 | PF01217 | 0.657 |
TRG_DiLeu_BaEn_2 | 94 | 100 | PF01217 | 0.462 |
TRG_DiLeu_BaEn_4 | 130 | 136 | PF01217 | 0.444 |
TRG_DiLeu_BaLyEn_6 | 287 | 292 | PF01217 | 0.523 |
TRG_ENDOCYTIC_2 | 44 | 47 | PF00928 | 0.402 |
TRG_ENDOCYTIC_2 | 94 | 97 | PF00928 | 0.385 |
TRG_ER_diArg_1 | 135 | 137 | PF00400 | 0.549 |
TRG_ER_diArg_1 | 187 | 189 | PF00400 | 0.697 |
TRG_NLS_MonoExtN_4 | 31 | 37 | PF00514 | 0.337 |
TRG_Pf-PMV_PEXEL_1 | 102 | 106 | PF00026 | 0.531 |
TRG_Pf-PMV_PEXEL_1 | 137 | 141 | PF00026 | 0.552 |
TRG_Pf-PMV_PEXEL_1 | 158 | 163 | PF00026 | 0.567 |
TRG_Pf-PMV_PEXEL_1 | 290 | 294 | PF00026 | 0.512 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1HT89 | Leptomonas seymouri | 64% | 98% |
A0A1X0NQ36 | Trypanosomatidae | 37% | 93% |
A0A3R7LN24 | Trypanosoma rangeli | 40% | 95% |
A0A3S5H510 | Leishmania donovani | 100% | 100% |
A4H3F2 | Leishmania braziliensis | 85% | 100% |
C9ZUN5 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 27% | 94% |
E9ACD5 | Leishmania major | 97% | 100% |
E9AJM3 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 96% | 100% |
V5DPV7 | Trypanosoma cruzi | 39% | 94% |